Medaptus, a leading provider of healthcare technology solutions, today announced that Rush University System for Health has selected Medaptus' Charge Infusion solution to automate coding and billing ...
– Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on Ocrevus levels in the blood over 12 weeks – – Ocrevus subcutaneous injection was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results